Chlamydia trachomatis infection
Introduction:
Chlamydia trachomatis is an obligate intracellular gramnegative like
bacterium and an important cause of sexually
transmitteddiseases
worldwide (de Muylder et al., 1990; Ville et al., 1991; den
Hartog
et al., 2005). Many chlamydial infections are asymptomatic, and
re-infections are common. If left untreated, Chlamydia has a
high tendency
to remain persistent in inflamed tissues of the upper genital
tract of patients with pelvic inflammatory disease (Cohen and
Brunham, 1999; den Hartog et al., 2006). Prolonged
inflammation
may lead to tissue scarring and occlusion of Fallopian tubes.
Although
many women are infected with C. trachomatis, only a minority
will
develop tubal factor infertility. Moreover, a clearance rate of
44.7%
has been reported in asymptomatic and untreated women after 1
year follow-up (Morre et al., 2002). These results imply that
host
genetic factors play an important role in modulating the immune
defence mechanisms and thereby determining the pathogenesis
of
chlamydial diseases. However, the genetic basis underlying this
phenomenon has remained unclear.
Genes involved in the immune response appear ideal candidates
for
further study, given their function and polymorphism, as well as
data
from previous studies (Cohen et al., 2000, 2003; Kinnunen et
al.,
2002). It has been found that, after C. trachomatis infection,
downregulation
of the major histocompatibility complex (MHC) class I is
one of the mechanisms C. trachomatis-infected cells use to
evade an
immune response involving recognition and destruction by
cytotoxic
T lymphocytes (Zhong et al., 2000). However, the downregulation
of MHC class I leads to activation of natural killer (NK) cells
because of a decreasing inhibitory signal generated by the
binding of
inhibitory receptors to their ligands Simultaneously, the NK
cell-activating ligands, such as major histocompatibility
complex class
I chain-related A (MICA), may be up-regulated. Through t
interaction between the activating ligands
and their corresponding
receptors, the activating signals of the NK cells increase.
Moreover, one of the most relevant cytokines involved in the
response against C. trachomatis is interferon-g (IFN-g)
(Srivastava
et al., 2008). One of the most important sources of IFN-g is
from
NK cells. Stimulation of NK cells by the NKG2D receptor by
means
of its ligand, MICA, results in the release of the cytokine IFN-g
(Bauer et al., 1999)). We therefore believe that the relationship
between polymorphism of the MICA ligand and susceptibility to
C. trachomatis infection deserves further study.
The MICA genes are situated 46 kb upstream of human
leucocyte
antigen B and encode a stress-inducible molecule with three
extracellular
domains (a1, a2 and a3), a transmembrane region and a
cytoplasmic
tail. Its domain structure is similar to MHC class I antigens
without b2-microglobulin (Bahram et al., 1994; Tieng et al.,
2002).
Like MHC class I genes, the MICA locus is highly polymorphic,
with
at least 53 alleles having been described.
At present, the role of MICA polymorphisms has not been
investigated
either in the susceptibility to the development of tubal pathology
or in C. trachomatis-associated tubal factor infertility. Therefore,
the
first objective of our study was to assess whether
polymorphisms of
MICA genes are associated with tubal pathology by comparing
Serology
Chlamydial antibody testing is a routine procedure in the
fertility workup.
Peripheral venous blood was collected for the analysis of IgG
antibodies
against C. trachomatis using commercially available enzyme
immunoassay
kits (Immuno-Biological Laboratories, Minnesota, USA). The
results
were obtained in terms of the mean absorbance (optical density,
OD)
at 450 nm. The antibody index of each determination was
calculated by
dividing the OD value of each sample by the cut-off value.
Positive
C. trachomatis specific IgG results were defined as antibody
index .1.1,
as recommended by the manufacturer. Samples with grey zone
values,
e.g. 1.0+0.1, were repeated and considered positive when the
resul
References:Bahram S, Bresnahan M, Geraghty DE, Spies T. A second
lineage of
mammalian major histocompatibility complex class I genes.
Proc Natl
Acad Sci USA 1994;91:6259–6263.
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies
T. Activation
of NK cells and T cells by NKG2D, a receptor for stressinducible
MICA. Science 1999;285:727–729.
Claman P, Honey L, Peeling RW, Jessamine P, Toye B. The
presence of
serum antibody to the chlamydial heat shock protein (CHSP60)
as a
diagnostic test for tubal factor infertility. Fertil Steril
1997;67:501–504.
Cohen CR, Brunham RC. Pathogenesis of Chlamydia induced
pelvic
inflammatory disease. Sex Transm Infect 1999;75:21–24.
Cohen CR, Sinei SS, Bukusi EA, Bwayo JJ, Holmes KK,
Brunham RC.
Human leukocyte antigen class II DQ alleles associated with
Chlamydia trachomatis tubal infertility. Obstet Gynecol
2000;95:72–77.
Cohen CR, Gichui J, Rukaria R, Sinei SS, Gaur LK, Brunham
RC.
Immunogenetic correlates for Chlamydia trachomatis-associated
tubal
infertility. Obstet Gynecol 2003;101:438–444.
de Muylder X, Laga M, Tennstedt C, Van Dyck E, Aelbers GN,
Piot P. The
role of Neisseria gonorrhoeae and Chlamydia trachomatis in
pelvic
inflammatory disease and its sequelae in Zimbabwe. J Infect Dis
1990;
162:501–505.
den Hartog JE, Land JA, Stassen FR, Slobbe-van Drunen ME,
Kessels AG,
Bruggeman CA. The role of Chlamydia genus-specific and
Downloaded from humrep.oxfordjournals.org by guest on February
5, 2011
species-specific IgG antibody testing in predicting tubal disease in
subfertile women. Hum Reprod 2004;19:1380–1384.
den Hartog JE, Land JA, Stassen FR, Kessels AG, Bruggeman CA.
Serological markers of persistent C. trachomatis infections in
women
with tubal factor subfertility. Hum Reprod 2005;20:986–990.
den Hartog JE, Ouburg S, Land JA, Lyons JM, Ito JI, Pena AS,
Morre SA. Do
host genetic traits in the bacterial sensing system play a role in the
development of Chlamydia trachomatis-associated tubal pathology
in
subfertile women? BMC Infect Dis 2006;6:122.
Gaudieri S, Leelayuwat C, Townend DC, Mullberg J, Cosman D,
Dawkins RL. Allelic and interlocus comparison of the PERB11
multigene family in the MHC. Immunogenetics 1997;45:209–216.
Kinnunen AH, Surcel HM, Lehtinen M, Karhukorpi J, Tiitinen A,
Halttunen M, Bloigu A, Morrison RP, Karttunen R, Paavonen J.
HLA
DQ alleles and interleukin-10 polymorphism associated with
Chlamydia trachomatis-related tubal factor infertility: a case-control
study. Hum Reprod 2002;17:2073–2078.
Morre SA, Van den Brule AJ, Rozendaal L, Boeke AJ, Voorhorst
FJ, De
Blok S, Meijer CJ. The natural course of asymptomatic Chlamydia
trachomatis infections: 45% clearance and no development of
clinical
PID after one-year follow-up. Int J STD AIDS 2002;13(Suppl. 2):
12–18.
Murillo LS, Land JA, Pleijster J, Bruggeman CA, Pena AS, Morre
SA.
Interleukin-1B (IL-1B) and interleukin-1 receptor antagonist (IL1RN)
gene polymorphisms are not associated with tubal pathology and
Chlamydia trachomatis-related tubal factor subfertility. Hum Reprod
2003;18:2309–2314.
Petersdorf EW, Shuler KB, Longton GM, Spies T, Hansen JA.
Population
study of allelic diversity in the human MHC class I-related MIC-A
gene. Immunogenetics 1999;49:605–612.
Rees MT, Downing J, Darke C. A typing system for the major
histocompatibility complex class I chain related genes A and B using
polymerase chain reaction with sequence-specific primers. Genet
Test
2005;9:93–110.
Srivastava P, Jha R, Bas S, Salhan S, Mittal A. In infertile women,
cells
from Chlamydia trachomatis infected sites release higher levels of
interferon-gamma, interleukin-10 and tumor necrosis factor-alpha
upon
heat-shock-protein stimulation than fertile women. Reprod Biol
Endocrinol
2008;6:20.
Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P,
Janin A,
Charron D, Toubert A. Binding of Escherichia coliadhesin AfaE to
CD55
triggers cell-surface expression of the MHC class I-related molecule
MICA. Proc Natl Acad Sci USA 2002;99:2977–2982.
Ville Y, Leruez M, Glowaczower E, Robertson JN, Ward ME. The
role of
Chlamydia trachomatis and Neisseria gonorrhoeae in the aetiology
of
ectopic pregnancy in Gabon. Obstet Gynaecol 1991;98:1260–1266.
Visser CJ, Tilanus MG, Tatari Z, Van der Zwan AW, Bakker R,
Rozemuller EH, Schaeffer V, Tamouza R, Charron D.
Sequencing-based typing of MICA reveals 33 alleles: a study on
linkage with classical HLA genes. Immunogenetics 1999;49:561–
566.
Zhang Y, Lazaro AM, Lavingia B, Stastny P. Typing for all known
MICA alleles
by group-specific PCR and SSOP. Hum Immunol 2001;62:620–631.
Zhang Y, Han M, Vorhaben R, Giang C, Lavingia B, Stastny P.
Study of
MICA alleles in 201 African Americans by multiplexed single
nucleotide extension (MSNE) typing. Hum Immunol 2003;64:130–
136.
Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcription
factor
RFX5 during the inhibition of both constitutive and interferon
gamma-inducible major histocompatibility complex class I
expression
in chlamydia-infected cells. J Exp Med 2000;191:1525–1534.
Zou Y, Bresnahan W, Taylor RT, Stastny P. Effect of human
cytomegalovirus on expression of MHC class I-related chains A.
J Immunol 2005;174:3098–3104.
Submitted on May 17, 2009; resubmitted on July 21, 2009; accepted
on August 27,
2009
MICA alleles and Chlamydia trachomatis 3095
Downloaded from humrep.oxfordjournals.org by guest on February
5, 2011